Medico-Legal and Bioethical Implications of Infectious Disease Epidemiology and Control Strategies
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: closed (25 November 2023) | Viewed by 375
Special Issue Editors
Interests: legal medicine; forensic medicine; forensic psychiatry; forensic gynecology; public health; health policy; population health management; risk management; bioethics; clinical ethics
Interests: legal medicine; forensic medicine; forensic gynecology; risk management; bioethics
Special Issue Information
Dear Colleagues,
As recently declared by the World Health Organization, the end of the pandemic COVID-19 is "in sight". It is undeniable that the pandemic caught the health systems of the world unprepared, even the most economically viable. The lack of a priori unique epidemiological protocols for the prevention and management of spreading infectious diseases of unknown origin (such as SARS-CoV-2) forced the use of prevention and control strategies based on empirical evidence. This has inevitably raised a number of bioethical issues (for example, the criteria for compulsory vaccination, the priority of access to treatment, and the severe social and work restrictions imposed during the first pandemic phase). In addition, the pandemic experience—in addition to highlighting widespread vaccination hesitation—has highlighted medico-legal issues regarding informed consent to compulsory vaccination and the need for parental consent in minors. Additionally, in reference to vaccines, the need to contain pandemic infection has opened the way for the first time to human challenge studies, the subject of intense bioethical debate. Finally, the pandemic has brought to light important medical–legal criticisms in the management of nosocomial infections, as well as to inhomogeneity in recognizing the infection contracted in the workplace as either an "occupational disease" or "accident".
The delicate epidemiological situation that we have faced necessarily constitutes, on the one hand, an opportunity to discuss the bioethical and medico-legal implications of the management and preventive strategies adopted, and, on the other hand, a starting point for formulating strategies and protocols useful for coping with infectious diseases.
Hence, this Special Issue of Vaccines, entitled “Medico-Legal and Bioethical Implications of Infectious Disease Epidemiology and Control Strategies”, aims to open a scientific debate on bioethical and medico-legal issues related to the prevention and management of infectious diseases, as well as possible new applicable strategies.
In this Special Issue, original research articles and reviews, as well as short communications, are welcome. Possibile topics inlude, but are not limited to:
- Studies on the definition and management of infectious diseases;
- Research on compulsory vaccinations and the need for informed consent and parental consent for minors;
- Studies to outline the professional responsibility of the health professional and health facilities in case of adverse reactions to compulsory vaccinations;
- Studies that highlight the bioethical and medico-legal implications of human challenge studies;
- Research on the protection of workers in the event of infectious diseases at work and their medico-legal classification;
- Studies proposing new interventions and protocols for the prevention and management of infectious diseases.
We look forward to receiving your contributions.
Dr. Andrea Cioffi
Dr. Camilla Cecannecchia
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioethics
- legal medicine
- infectious disease
- prevention
- vaccines
- COVID-19
- public health
- health care acquired infections
- occupational infections
- professional liability
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
